此页面是自动翻译的，不保证翻译的准确性。请参阅 英文版 对于源文本。

Development and Preliminary Application Evaluation of a Clinical Decision Support Training Platform for Dementia Care

2026年9月14日 更新者：Huei-Ling Huang、Chang Gung Memorial Hospital

This study consists of two phases: an observational phase and a single-arm interventional phase. In Phase 1, qualitative interviews will be conducted to explore the decision-making challenges faced by second-year students in a two-year undergraduate program who are approaching graduation when providing care for people with dementia. In Phase 2, a single-arm intervention will be implemented using an interactive web-based digital clinical decision support training platform. The following research questions will be examined:

  1. Does the interactive web-based digital clinical decision support training platform significantly improve students' decision-making competency in providing assistance with activities of daily living for people with dementia?
  2. Does the interactive web-based digital clinical decision support training platform significantly improve students' judgment competency in managing behavioral problems associated with dementia?
  3. Does the interactive web-based digital clinical decision support training platform significantly improve students' competency in supporting family caregivers experiencing caregiving burden and in connecting them with appropriate resources?

研究概览

地位

尚未招聘

条件

干预/治疗

研究类型

介入性

注册 (估计的)

130

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息，以及有关进行该研究的地点的信息。

学习联系方式

参与标准

研究人员寻找符合特定描述的人，称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 成人
  • 年长者

接受健康志愿者

是的

描述

Inclusion Criteria in Phase 1:

  1. Aged 20 years or older.
  2. Willing to provide written informed consent.
  3. Currently a second-year student in the Department of Gerontology and Health Care Management.
  4. Has prior practicum experience in geriatric care or practical experience in dementia care.
  5. Voluntarily agrees to participate in the study.

Inclusion Criteria in Phase 2:

  1. Aged 20 years or older.
  2. Willing to provide written informed consent.
  3. Currently a second-year student in the Department of Gerontology and Health Care Management.
  4. Has prior practicum experience in geriatric care or practical experience in dementia care.
  5. Voluntarily agrees to participate in the study.
  6. Able to operate the information platform. Exclusion Criteria in Phase 1 and 2: Students who have taken a leave of absence from school or who decline to provide informed consent to participate.

学习计划

本节提供研究计划的详细信息，包括研究的设计方式和研究的衡量标准。

研究是如何设计的？

设计细节

  • 主要用途：卫生服务研究
  • 分配：不适用
  • 介入模型：单组作业
  • 屏蔽：无（打开标签）

武器和干预

参与者组/臂
干预/治疗
实验性的：care decision support training group
The care decision support training group will receive an educational intervention using an interactive web-based digital care decision support training platform.
其他：care decision support training platform program
The participants will receive an educational intervention using an interactive web-based digital care decision support training platform. The training is centered on scenario-based modules and incorporates guidance on decision branches, situational judgment, and care plan development.

研究衡量的是什么？

主要结果指标

结果测量
措施说明
大体时间
Dementia Care Professional Competency Assessment Scale
大体时间：Baseline and after completion of all training modules (up to 18 weeks)
  1. The Dementia Care Professional Competency Assessment Scale was developed in our previous research supported by the Taiwan Ministry of Science and Technology (Grant No. 106-2511-S-255-002-MY3) to assess dementia care competency among students.
  2. The original scale contains nine subscales with 74 items. In this study, three subscales comprising 33 items are used. Each item is rated on a 5-point Likert scale from 1 to 5, with higher scores indicating greater dementia care competency.
Baseline and after completion of all training modules (up to 18 weeks)

次要结果测量

结果测量
措施说明
大体时间
Problem solving, Teamwork Competency Assessment Scale
大体时间：Baseline and after completion of all training modules (up to 18 weeks)
  1. The Dementia Care Professional Competency Assessment Scale was developed in our previous research supported by the Taiwan Ministry of Science and Technology (Grant No. 106-2511-S-255-002-MY3) to assess dementia care competency among students.
  2. The scale contains 22 items, including 10 items assessing problem-solving competency and 12 items assessing teamwork competency. Higher scores indicate greater problem-solving and teamwork competency.
Baseline and after completion of all training modules (up to 18 weeks)
Participants' Experiences and Feedback on the Training Program
大体时间：After completion of all training modules (up to 18 weeks)
Students will complete a feedback form to provide their perceptions and experiences regarding the interactive web-based care decision support training program. The form includes open-ended questions regarding their learning experiences, perceived usefulness of the training, difficulties encountered, and suggestions for improvement. Qualitative responses will be analyzed to explore participants' experiences and perspectives regarding the training program.
After completion of all training modules (up to 18 weeks)

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

赞助

Chang Gung Memorial Hospital

合作者

Chang Gung University of Science and Technology
National Science and Technology Council, Taiwan

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查，以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (估计的)

2026年10月1日

初级完成 (估计的)

2027年6月1日

研究完成 (估计的)

2027年7月1日

研究注册日期

首次提交

2026年9月9日

首先提交符合 QC 标准的

2026年9月14日

首次发布 (实际的)

2026年9月16日

研究记录更新

最后更新发布 (实际的)

2026年9月16日

上次提交的符合 QC 标准的更新

2026年9月14日

最后验证

2026年9月1日

更多信息

与本研究相关的术语

关键字

其他相关的 MeSH 术语

其他研究编号

  • NSTC 115-2637-B-255-001-

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)？

不

IPD 计划说明

There is currently no plan to share individual participant data from this study with other researchers. Participants may separately consent to the future use of their de-identified data for related research. Any such future use will be subject to applicable ethical review and the scope of the participant's consent.

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索，没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求，请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改，我们的网站上也会自动更新.

订阅